01969nam a2200337 4500 5856 9291680877 5856 20010326d1999 y0pory50 ba eng Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs European Monitoring Centre for Drugs and Drug Addiction Luxembourg Office for Official Publication of the European Communities 1999 114 p. il. 21 cm Implemention of the joint action Informação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: https:/www.emcdda.org Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs. Council decision of 13 September 1999 defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties. Europol-EMCDDA progress report on 4-MTA in accordance with article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Review of the pharmacotoxicological data on 4-MTA. Public health risks of 4-MTA: epidemiological evidence. Sociological and criminological evidence on the risks of 4-MTA. DROGAS ILÍCITAS 6631 SUBSTÂNCIAS PSICOTRÓPICAS 6333 COOPERAÇÃO INTERNACIONAL 581 SAÚDE PÚBLICA 1370 EUROPOL 103050 CONSELHO DA EUROPA 6334 EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA 5764 DRO319 0 DRO_319_000000000000000 2021-12-17 3748 8338 DGRSP DGRSP DGRSP3748108980 DRO319 2021-12-17 0 MO oferta